Highlights from ISEV 2022: In-Person Inspires In-Depth EV/Exosome Discussions & Analysis June 16, 2022 Conference Highlights, Exosomes / Extracellular Vesicles
Life at the Roost: An Interview with Elie Zakhem, Manager of Process Development June 01, 2022 Corporate
FBS-Based Media — Is It Time to Transition Between Traditions? May 18, 2022 Cell Therapy, Quality & Regulatory
“Where Your Eyes Don’t Go” When Considering Adipose Mesenchymal Stromal/Stem Cells April 27, 2022 Cell Therapy, MSCs & Characterization
Extracellular Vesicle/Exosome Upstream Process Development: Maximizing Productivity to Accelerate… April 01, 2022 Biomanufacturing, Exosomes / Extracellular Vesicles
Life At the Roost: A Balance of Work, Team, & Family in the Frederick Community March 17, 2022 Corporate
Maintaining CQAs as Manufacturing Processes are Scaled from 2D to 3D Bioreactor Culture February 28, 2022 Biomanufacturing, Quality & Regulatory
MSCs “Versus” or MSCs “Via” T Cells for Cell & Gene Therapy? February 07, 2022 Biomanufacturing, Cell Therapy